Pfizer and Valneva announce relaunch of Lyme disease vaccine trial
HQ Team December 6, 2023: Pfizer and Valneva SE announced that they have finalized enrolment in the VALOR Phase III trial of their
HQ Team December 6, 2023: Pfizer and Valneva SE announced that they have finalized enrolment in the VALOR Phase III trial of their
HQ Team December 6, 2023: Junior hospital doctors, who make up about half of the National Health Service (NHS) medical workforce in England,
HQ Team December 6, 2023: France has upgraded its level of bird flu risk to ‘high’ from ‘moderate’ to ensure better protection and
HQ Team December 5, 2023: Greenhouse gases have “turbocharged” drastic glacier loss and sea-level rise during the past decade and climate shocks are
HQ Team December 5, 2023: As cities light up during the night, the pollution caused by the illumination sets an ‘ecological trap’ for
By K. Leelamoni November 5, 2023: Outbreaks of pneumonia affecting children in parts of northern China, the US, the Netherlands, and Denmark are higher than
HQ Team December 5, 2023: The response of immune cells inside the protective covering of the brain may lead to a cognitive decline
HQ Team December 4, 2023: In a strategic push into the obesity and diabetes treatment market, Roche, a leading pharmaceutical company, has finalized
HQ Team December 4, 2023: The COP28 has unveiled a $1.7 billion funding plan to meet climate and diversity goals. The key objectives
HQ Team December 4, 2023: Eli Lilly and Company got a second accelerated approval from the Food and Drug Administration for its blood